1. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27:283–290.
Article
2. Stefanson E. Oxygen and diabetic eye disease. Graefes Arch Clin Exp Ophthalmol. 1990; 228:120–123.
3. Frisch GD, Shawaluk PD, Adams DO. Remote nerve fibre bundle alterations in the retina as caused by argon laser photocoagulation. Nature. 1974; 248:433–435.
Article
4. Retineour RJ, Kozousek V, Chauhan BC. The effect of panretinal photocoagulation for diabetic retinopathy on retinal nerve fiber layer thickness and optic disc topography. Br J Ophthalmol. 2009; 93:838–839.
5. Kim J, Woo SJ, Ahn J, et al. Long-term temporal changes of peripapillary retinal nerve fiber layer thickness before and after panretinal photocoagulation in severe diabetic retinopathy. Retina. 2012; 32:2052–2060.
Article
6. Mwanza JC, Budenz DL, Godfrey DG, et al. Diagnostic performance of optical coherence tomography ganglion cell--inner plexiform layer thickness measurements in early glaucoma. J Ophthalmology. 2014; 121:849–854.
Article
7. Sihota R, Sony P, Gupta V, et al. Diagnostic capability of optical coherence tomography in evaluating the degree of glaumcomatous retinal nerve fiber damage. Invest Ophthalmo Vis Sci. 2006; 47:2006–2010.
8. Mwanza JC, Durbin MK, Budenz DL, et al. Profile and predictors of normal ganglion cell-inner plexiform layer thickness measured with frequency-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2011; 52:7872–7879.
Article
9. Mwanza JC, Oakley JD, Budenz DL, et al. Macular ganglion cell-inner plexiform layer: automated detection and thickness reproducibility with spectral domain-optical coherence tomography in glaucoma. Invest Ophthalmol Vis Sci ophthalmol. 2011; 52:8323–8329.
Article
10. Kim JJ, Im JC, Shin JP, et al. One-year follow-up of macular ganglion cell layer and peripapillary retinal nerve fiber layer thickness changes after panretinal photocoagulation. Br J ophthalmol. 2014; 98:213–217.
11. Roohipoor R, Dantism S, Ahmadrji A, et al. Subfoveal choroidal thickness after panretinal photocoagulation with red and green lase in bilateral proliferative diabetic retinopathy patients: short term results. J Ophthalmol. 2016; 2016:9364861.
12. Park YR, Jee D. Changes in peripapillary retinal nerve fiber layer thickness after pattern scanning laser photocoagulation in patients with diabetic retinopathy. Korean J Ophthalmol. 2014; 28:220–225.
Article
13. Shin JS, Lee YH. Changes in macular retinal layers and peripapillary nerve fiber layer thickness after 577-nm pattern scanning laser in patients with diabetic retinopathy. Korean J Ophthalmol. 2017; 31:497–507.
Article
14. Mendívil A, Cuartero V, Mendívil MP. Ocular blood flow velocities in patients with proliferative diabetic retinopathy before and after scatter photocoagulation: a prospective study. Eur J Ophthalmol. 1995; 5:259–264.
Article
15. Hiroshiba N, Ogura Y, Nishiwaki H, et al. Alterations of retinal microcirculation in response to scatter photocoagulation. Invest Ophthalmol Vis Sci. 1998; 39:769–776.
16. Nonaka A, Kiryu J, Tsujikawa A, et al. Inflammatory response after scatter laser photocoagulated retina. Invest Ophthalmol Vis Sci. 2002; 43:1204–1209.
17. Itaya M, Sakurai E, Nozaki M, et al. Upregulation of VEGF in murine retina via monocyte recruitment after retinal scatter laser photocoagulation. Invest Ophthalmol Vis Sci. 2007; 48:5677–5683.
Article
18. Jampol LM, Odia I, Glassman AR, et al. Panretinal photocoagulation versus ranibizumab for proliferative diabetic retinopathy comparison of peripapillary retinal nerve fiber layer thickness in a randomized clinical trial. Retina. 2017; DOI:
10.1097/IAE.0000000000001909.
19. Gillies MC, Su T, Stayt J, et al. Effect of high glucose on permeability of retinal capillary endothelium in vitro. Invest Ophthalmol Vis Sci. 1997; 38:635–642.
20. Rungger-Brändle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000; 41:1971–1980.
21. Kim JT, Lee JK, Moon NJ, Cho HK. Analysis of the optic nerve head and RNFL thickness using optical coherence tomography in diabetes. J Korean Ophthalmol Soc. 2008; 49:935–941.
Article
22. Apple DJ, Wyhinny GJ, Goldenberg MF, et al. Experimental argon laser photocoagulation. I. Effects on retinal nerve fiber layer. Arch Ophthalmol. 1976; 94:137–144.
23. Yang HS, Kim JG, Cha JB, et al. Quantitative analysis of neural tissues around the optic disc after panretinal photocoagulation in patients with diabetic retinopathy. Plos one. 2017; 12:e0186229. eCollection 2017.
Article
24. Tso MO, Wallow IH, Elgin S. Experimental photocoagulation of the human retina: I. Correlation of physical, clinical, and pathologic data. Arch Ophthalmol. 1977; 95:1035–1040.
25. Van Dijk HW, Verbraak FD, Stehouwer M, et al. Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy. Vision Res. 2011; 51:224–228.
Article
26. Lee SB, Kwag JY, Lee HJ, et al. The longitudinal changes of retinal nerve fiber layer thickness after panretinal photocoagulation in diabetic retinopathy patients. Retina. 2013; 33:188–193.
Article
27. Maeshima K, Utsugi-Sutah N, Otani T, Kishi S. Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy. Retina. 2004; 24:507–511.
Article
28. Shin YJ, Kyoung HS, Park KH, Yu HG. The analysis of retinal nerve fiber layer in the patients with nonproliferative diabetic retinopathy. J Korean Ophthalmol Soc. 2003; 44:2010–2015.